Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb

Autor: B L Rothman, N Kennure, K A Kelley, M Katz, T M Aune

Publikováno v: The Journal of Immunology. 151:6036-6042

Regulation of lymphocyte responses to activation of the CD3/TCR complex by other cell surface proteins expressed on lymphocytes is a well established phenomenon. CD44 is an example of such a cell surface protein. Anti-CD44 mAb have been identified wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84d85a0b86f8c3a926005412dedb274e
https://doi.org/10.4049/jimmunol.151.11.6036

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review.

Autor: Gerges A; Bioscience Department, London Metropolitan University, 166-220 Holloway Road, London, N7 8DB, England, United Kingdom., Canning U; Bioscience Department, London Metropolitan University, 166-220 Holloway Road, London, N7 8DB, England, United Kingdom.

Publikováno v: ChemMedChem [ChemMedChem] 2024 May 02; Vol. 19 (9), pp. e202300535. Date of Electronic Publication: 2024 Mar 26.

Introduction of chiral 2-(aminoalkyl) substituents into 5-amino-1,3-oxazol-4-ylphosphonic acid derivatives and their use in phosphonodipeptide synthesis.

Autor: Lukashuk, O. I., Abdurakhmanova, E. R., Kondratyuk, K. M., Golovchenko, O. V., Khokhlov, K. V., Brovarets, V. S., Kukhar, V. P.

Publikováno v: RSC Advances; 2015, Vol. 5 Issue 15, p11198-11206, 9p

Molecules Engineered Against Oncogenic Proteins and Cancer : Discovery, Design, and Development

Autor: E. J. Corey, Yong-Jin Wu

Molecules Engineered Against Oncogenic Proteins and Cancer A comprehensive review of the latest molecular advances in cancer treatment Featuring 91 total small molecule kinase/KRAS inhibitors, 80 of which are FDA-approved, Molecules Engineered Agains